Chugai seeks Japanese approval for Herceptin in combination with Xeloda for gastric cancer March 22, 2010
Vorinostat exhibits safety and tolerability in phase II trial in advanced renal cell carcinoma March 22, 2010
Macrophage migration inhibitory factor inhibitors active in bladder cancer, diabetes models March 19, 2010
Abraxis' Abraxane meets primary endpoint in phase III non-small cell lung cancer trial March 18, 2010
RSS